In the present study, the expression of PD1 on T cell populations from splenocytes and single tumor cells and that of PDL1 on glioblastoma target cells and single tumor cells were confirmed to verify the efficiency of anti-PD1 treatment. This evidence concerns the gene CD274 and glioblastoma.